Jury Awards $1.5 Million in Pennsylvania Prempro Case
Last week a Pennsylvania state jury awarded $1.5 million in compensatory damages to a women diagnosed with breast cancer after taking the osteoporosis drug Prempro for 5 years. However, this is only the first of two parts of the trial. In the second phase of the trial, plaintiff's attorney Ken Suggs will have to convince the jury that Wyeth Pharmaceuticals, the maker of Prempro, failed to adequately warn of the breast cancer risk. If the jury finds that Wyeth did fail to warn, then they may add punitive damages. If however they do not find that Wyeth failed to warn, the initial compensatory award will be nullified.
Post A Comment / Question